WNK2 Inhibits Autophagic Flux in Human Glioblastoma Cell Line

Autor(es)

Vieira Alves, Ana Laura ^[1] ; Costa, Angela Margarida ^{[2, 3]} ; Martinho, Olga ^{[1, 2, 3]} ; da Silva, Vinicius Duval ^[1] ; Jordan, Peter ^{[4, 5]} ; Oliveira Silva, Viviane Aline ^[1] ; Reis, Rui Manuel ^{[1, 2, 3]}

Afiliação do(s) autor(es)

^[1] Barretos Canc Hosp, Mol Oncol Res Ctr, BR-14784400 Barretos - Brazil

^[2] ICVS 3Bs PT Govt Associate Lab, P-4806909 Braga - Portugal

^[3] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Med, P-4710057 Braga - Portugal

^[4] Natl Hlth Inst Doutor Ricardo Jorge, Dept Human Genet, P-1649016 Lisbon - Portugal

^[5] Univ Lisbon, BioISI Biosyst & Integrat Sci Inst, Fac Sci, P-1749016 Lisbon - Portugal

• Tipo de documento: Artigo Científico
• Fonte: CELLS; v. 9, n. 2 FEB 2020.
• Citações Web of Science: 0

Resumo

Autophagy is a cell-survival pathway with dual role in tumorigenesis, promoting either tumor survival or tumor death. WNK2 gene, a member of the WNK (with no lysine (K)) subfamily, acts as a tumor suppressor gene in gliomas, regulating cell migration and invasion; however, its role in autophagy process is poorly explored. The WNK2-methylated human glioblastoma cell line A172 WT (wild type) was compared to transfected clones A172 EV (empty vector), and A172 WNK2 (WNK2 overexpression) for the evaluation of autophagy using an inhibitor (bafilomycin A1-baf A1) and an inducer (everolimus) of autophagic flux. Western blot and immunofluorescence approaches were used to monitor autophagic markers, LC3A/B and SQSTM1/p62. A172 WNK2 cells presented a significant decrease in LC3B and p62 protein levels, and in LC3A/B ratio when compared with control cells, after treatment with baf A1 + everolimus, suggesting that WNK2 overexpression inhibits the autophagic flux in gliomas. The mTOR pathway was also evaluated under the same conditions, and the observed results suggest that the inhibition of autophagy mediated by WNK2 occurs through a mTOR-independent pathway. In conclusion, the evaluation of the autophagic process demonstrated that WNK2 inhibits the autophagic flux in glioblastoma cell line. (AU)

• Processo FAPESP: 16/18907-0 - Caracterização do envolvimento da proteína WNK2 no tráfego vesicular autofágico e endocítico em gliomas
• Beneficiário: Ana Laura Vieira Alves
• Modalidade de apoio: Bolsas no Brasil - Mestrado